Publication:
An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

Simple item page
dc.contributor.authorDane, F.
dc.contributor.authorÖzgürdal, K.
dc.contributor.authorYalçın, S.
dc.contributor.authorBenekli, M.
dc.contributor.authorAykan, N. F.
dc.contributor.authorYücel, I.
dc.contributor.authorÖzkan, M.
dc.contributor.authorEvrensel, T.
dc.contributor.authorSevinç, A.
dc.contributor.authorCoşkun, H. S.
dc.contributor.authorŞanlı, U. S.
dc.contributor.authorKara, I. O.
dc.contributor.buuauthorEVRENSEL, TÜRKKAN
dc.contributor.orcid0000-0002-9732-5340
dc.contributor.researcheridAAJ-1027-2021
dc.date.accessioned2024-08-02T06:41:55Z
dc.date.available2024-08-02T06:41:55Z
dc.date.issued2015-06-01
dc.description.abstractBu çalışma, 1-4 Temmuz 2015 tarihlerinde Barcelona'da düzenlenen ESMO 17. Dünya Gastrointestinal Kanser Kongresinde bildiri olarak sunulmuştur.
dc.description.sponsorshipESMO
dc.identifier.doi10.1093/annonc/mdv233.253
dc.identifier.issn0923-7534
dc.identifier.issueSupplement 4
dc.identifier.urihttps://doi.org/10.1093/annonc/mdv233.253
dc.identifier.urihttps://hdl.handle.net/11452/43649
dc.identifier.volume26
dc.identifier.wos000357047400123
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherOxford University Press
dc.relation.journalAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.subjectOncology
dc.titleAn open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublicationeceff514-6af7-4c3b-a146-b77546565a6c
relation.isAuthorOfPublication.latestForDiscoveryeceff514-6af7-4c3b-a146-b77546565a6c

Files

Collections

Yeni Yayınlar